Past Issues – Page 6 – The Cancer Letter

Past issues are only available to subscribers. If you are not a member, click here to join.

Issue 29 - Jul. 17, 2020

TCL46-29 (226 downloads)

Future of telehealth uncertain as CMS, private insurers reexamine payment policies put in place in March
Summer of 2020 was supposed to be a brief period of respite between Wave 1 and Wave 2 of COVID-19, but out of sheer stubbornness, for reasons political, or both, SARS-CoV-2 didn’t get the message.
COVID-19 and cancer: AACR convenes a meeting to explore a research agenda
A conference organized by the American Association for Cancer Research July 20-22 will bring together oncologists from academia, industry and government to identify ways for cancer researchers to inform studies of COVID-19.
Conversation with The Cancer Letter
Lucio Gordan: Patients must have the option of telehealth to avoid COVID-19 exposure
As cases of COVID-19 surge in Florida, Lucio Gordan, managing physician and president of Florida Cancer Specialists and Research Institute, is working to increase the role of telehealth.
Conversation with The Cancer Letter
Giuseppe Curigliano: The COVID-19 curve in the U.S. will never decrease, like in Italy
In early March, when Giuseppe Curigliano, an oncologist in Milan, first spoke with The Cancer Letter about COVID-19, the situation in Italy was “like being in a war zone” (The Cancer Letter, March 11, 2020).
ODAC votes Yes on advanced multiple myeloma agent with ocular toxicity
The FDA Oncologic Drugs Advisory Committee July 14 voted 12-0 to recommend approval for belantamab mafodotin for relapsed or refractory multiple myeloma.
In Brief
- ASCO opens search for chief medical officer
- Nunez-Smith named director of Center for Community Engagement and Health Equity at Yale
- Yale receives $11 million SPORE renewal for lung cancer research
- Winship glioblastoma project receives $500,000
- NICE, Flatiron to develop RWE research methodologies
- MD Anderson and Sanofi collaborate on R&D program
- Hackensack Meridian and Merck form COVID-19 research collaboration
- Cohen named regional director of Oncology Services, Southern Region at RWJBarnabas Health
- Cancer groups urge Trump to reconsider withdrawal from WHO
Clinical Roundup
- St. Jude researchers create analytic tool to identify what drives tumor growth
- NCCN translates tool that gauges mental health of cancer patients
Drugs & Targets
- Pfizer and BioNTech receive FDA Fast Track designation for investigational COVID-19 vaccine candidates
- Ashion Analytics receives Medicare coverage for assay for advanced solid tumors

Issue 28 - Jul. 10, 2020

TCL46-28 (254 downloads)

$5.275 billion for NIH is a healthy chunk of change—but read the fine print
A House subcommittee July 7 marked up a spending bill that proposes a $5.275 billion increase for NIH.
Depending on how you count, the bill that has cleared the Subcommittee on Labor, HHS, Education and Related Agencies would provide one of the biggest raises in NIH history.
USPSTF broadens age range, risk threshold in new recommendation for lung cancer screening
The U.S. Preventive Services Task Force has recommended expanding the eligible age range and broadening the risk threshold for annual low-dose CT screening for lung cancer.
Conversation with The Cancer Letter
USPSTF’s Michael Barry: Recommendation on lung cancer screening aims to reduce mortality
By making lung cancer screening available to a larger population, the new guideline from the U.S. Preventive Services Task Force could save an additional 120 lives per 100,000 Americans, said Michael J. Barry, a member of the Task Force, and a professor of medicine at Harvard Medical School.
Conversation with The Cancer Letter
Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio
Last time Ruben Mesa spoke with The Cancer Letter, COVID-19 was under control in San Antonio and the environs—or so it seemed.
COVID-19 Updates
- Yale researchers identify COVID-19 blood clotting cause
In Brief
- Theoret, Beaver, Kim, Amiri-Kordestani named to new positions at FDA
- Müschen named director of Center of Molecular and Cellular Oncology at Yale
- Friedman named associate director for community science and health outcomes at Vanderbilt
- Mehnert joins NYU Langone as associate director, clinical research
- Yale researchers awarded $2.8M NCI Cancer Systems Immunology grant
- Thermo Fisher and Chugai sign companion diagnostic agreement
Funding Opportunities
DoD Pancreatic Cancer Research Program funding opportunities for FY20
The FY20 Defense Appropriations Act provides funding to the Department of Defense Pancreatic Cancer Research Program to support a collaborative pancreatic cancer research paradigm that reduces the burden of pancreatic cancer.
Clinical Roundup
- Drug screens and CRISPR combine to make better cancer drugs, collaboration of researchers say
- Fasting Mimicking Diets may enhance effectiveness of chemotherapy in cancer patients
Drugs & Targets
- Inqovi approved by FDA for at-home MDS treatment
- Keytruda’s sBLA receives Priority Review from FDA for second-line treatment of relapsed or refractory classical Hodgkin lymphoma
- Lynparza approved in EU for germline BRCA-mutated metastatic pancreatic cancer

Issue 27 - Jul. 2, 2020

TCL46-27 (202 downloads)

Conversation with The Cancer Letter
Northwell Health reopens cancer services after COVID-19 deluge
New York health system explores NCI designation in affiliation with Cold Spring Harbor Laboratory
Any way you look at it, Northwell Health, New York’s largest health system, took a massive hit from COVID-19.
Northwell has treated over 50,000 COVID patients, admitting over 15,000 of them to its hospitals—more than any such system in the U.S.
NCI BSA approves nine new and reissue concepts
The NCI Board of Scientific Advisors has approved nine new and reissue concepts—Request for Applications, Cooperative Agreement, Request for Proposals, and Program Announcements with special receipt, referral and review.
In Brief
- Yale Cancer Center receives $2.8M NCI cancer systems immunology grant
- USC Norris receives $5 million for cancer drug discoveries
- Alexander Drilon named chief of the Early Drug Development Service at MSK
- Nancy R. Daly named CEO of Conquer Cancer, the American Society of Clinical Oncology Foundation
- ASCO’s Association for Clinical Oncology establishes PAC
- Florida Cancer Specialists & Research Institute breaks ground for new location
Trials & Tribulations
(Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients
Approximately two-thirds of the NCI Community Oncology Research Programs, serve states in which the rural population exceeds 30%.
Clinical Roundup
- NCCN Guidelines for patients can help patients recognize side-effects of immunotherapy
Drugs & Targets
- Phesgo receives FDA approval in breast cancer indication for at home treatment
- Keytruda receives FDA approval as first-line immunotherapy for MSI-H/dMMR MCC
- Bavencio receives FDA approval for urothelial carcinoma maintenance treatment
- Reblozyl approved by European Commission for transfusion-dependent anemia in adults with MDS or beta thalassemia
- Guardant Health launches real-world clinical-genomic platform to accelerate precision oncology drug development
NCI Trials
NCI Trials for July 2020
The National Cancer Institute approved the following clinical research studies last month.
For further information, contact the principal investigator listed.

Page 6 of 130« First «...2 3 4 567 8 9 10 11...20 30 40 50 60 70 80 90 100 110...»Last »

Future of telehealth uncertain as CMS, private insurers reexamine payment policies put in place in March

COVID-19 and cancer: AACR convenes a meeting to explore a research agenda

Conversation with The Cancer Letter

Lucio Gordan: Patients must have the option of telehealth to avoid COVID-19 exposure

Conversation with The Cancer Letter

Giuseppe Curigliano: The COVID-19 curve in the U.S. will never decrease, like in Italy

ODAC votes Yes on advanced multiple myeloma agent with ocular toxicity

In Brief

Clinical Roundup

Drugs & Targets

$5.275 billion for NIH is a healthy chunk of change—but read the fine print

USPSTF broadens age range, risk threshold in new recommendation for lung cancer screening

Conversation with The Cancer Letter

USPSTF’s Michael Barry: Recommendation on lung cancer screening aims to reduce mortality

Conversation with The Cancer Letter

Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio

COVID-19 Updates

In Brief

Funding Opportunities

DoD Pancreatic Cancer Research Program funding opportunities for FY20

Clinical Roundup

Drugs & Targets

Conversation with The Cancer Letter

Northwell Health reopens cancer services after COVID-19 deluge

New York health system explores NCI designation in affiliation with Cold Spring Harbor Laboratory

NCI BSA approves nine new and reissue concepts

In Brief

Trials & Tribulations

(Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients

Clinical Roundup

Drugs & Targets

NCI Trials

NCI Trials for July 2020